Schedule 13G ownership disclosure
EFFECTOR THERAPEUTICS INC
Security class unavailable · CUSIP: 28202V108
Event date: 2023-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,413,175
- Percent of class
- 2.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-24-010616
- Form type
- SC 13G
- Filer
- Altitude Life Science Ventures Fund II, L.P.
- CIK
- CIK 1638820
- Filed
- Feb 05, 2024
- Reporting period
- Dec 31, 2023
- Description
- Schedule 13G beneficial ownership